In neuroblastoma, ALK activity has been shown to promote transcription of MYCN through phosphorylation of ERK5, a member of the MAPK family, in a PI3K-dependant manner thus integrating ALK effector signaling and MYC regulation [22, 30]. The gene discussed is ALK; the disease is neuroblastoma.